Cambridge, MA, United States of America

Christel Iffland

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 64(Granted Patents)


Location History:

  • Arlington, MA (US) (2017 - 2023)
  • Cambridge, MA (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christel Iffland in Cancer Treatment

Introduction

Christel Iffland, a brilliant inventor based in Cambridge, MA, has made significant strides in the field of cancer research through her groundbreaking innovations. With a remarkable portfolio of six patents, she is recognized for developing novel therapeutic compositions that enhance immune responses against tumors.

Latest Patents

Among her latest patents, one notable invention is the "Anti-PD-L1 antibodies and uses thereof." This application focuses on anti-PD-L1 antibodies that enhance T-cell function, targeting T cell dysfunctional disorders such as tumor immunity and cancer treatment. Another significant patent is the "Monoclonal antibody directed to FGFR1," which involves antibodies that specifically bind to FGFR1, effectively neutralizing human, macaque, and mouse forms of this receptor. This invention also includes nucleic acids that encode these antibodies, along with their potential diagnostic and therapeutic applications in oncology.

Career Highlights

Throughout her career, Iffland has worked with well-respected organizations such as Merck Patent GmbH and Ares Trading S.A. Her contributions in these companies have been pivotal in advancing monoclonal antibody research, directly impacting cancer therapy.

Collaborations

Iffland has collaborated with esteemed colleagues, including Qi An and Horacio G Nastri, enhancing the research and development of innovative medical solutions. These partnerships have helped in fostering a collaborative environment to push the boundaries of cancer treatment.

Conclusion

Christel Iffland’s inventions showcase her commitment to revolutionizing cancer therapies through innovative antibody research. Her work not only highlights her individual prowess as an inventor but also emphasizes the importance of collaboration in scientific advancements. As cancer treatment continues to evolve, her contributions will undoubtedly play a crucial role in improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…